SoftBank CEO Masayoshi Son. Photo: Tomohiro Ohsumi/Getty Images

SoftBank CEO Masayoshi Son on Monday promised institutional investors that he'll do a better job of listening to their concerns, but stopped well short of saying that they'll change his mind.

The state of play: Son was "interviewed" by Goldman Sachs investment banking co-head Dan Dees, at a private event in New York.

  • It was planned before Elliott Management took over a multi-billion dollar stake in SoftBank, and began pushing for stock buyback, greater transparency and fewer private company investments until outside capital is secured for Vision Fund 2.
  • The goal was to calm investor nerves, particularly in the wake of WeWork.

Son didn't commit to following any of Elliott's proposals, but did express some past fondness for buybacks and a willingness to add more independent directors, per sources in the room.

  • He also reiterated recent comments about how it could be at least another year until Vision Fund 2 holds a first close, with intervening investments to be funded by the firm itself (and Vision Fund partners).
  • He also took a playful poke at critics, by noting internal resistance to his original investment in Alibaba.

The bottom line: Son appears bowed but not broken. Likely because he's one of the few investors who rode the dotcom train from boom to bust and back again. He plans to keep doing things his way, buttressed by a few cosmetic concessions.

Go deeper

Supreme Court Justice Ruth Bader Ginsburg dies at 87

Ruth Bader Ginsburg. Photo: Tom Brenner/Getty Images

Justice Ruth Bader Ginsburg has died of metastatic pancreatic cancer at age 87, the Supreme Court announced Friday evening.

Why it matters: Ginsburg had suffered from serious health issues over the past few years. Her death sets up a fight over filling a Supreme Court seat with less than 50 days until the election.

NYT: White House drug price negotiations broke down over $100 "Trump Cards"

President Trump with Mark Meadows, his chief of staff, on Sept. 3 at Andrews Air Force Base in Maryland. Photo: Mandel Ngan/AFP via Getty Images

Negotiations on a deal between the White House and pharmaceutical industry to lower drug prices broke down last month after Mark Meadows, the president's chief of staff, insisted that drugmakers pay for $100 cash cards to be mailed to seniors before the election, according to the New York Times.

Why it matters: Some of the drug companies feared that in agreeing to the prescription cards — reportedly dubbed "Trump Cards" by some in the pharmaceutical industry — they would boost Trump's political standing weeks ahead of Election Day with voters over 65, a group that is crucial to the president's reelection bid, per the Times.

In photos: Virginians line up for hours on first day of early voting

Photo: Andrew Caballero-Reynolds/AFP via Getty Images

In some parts of Virginia, people waited in line up to four hours to cast their ballots on the first day of early voting, according to the Washington Post.

The big picture: The COVID-19 pandemic seems to already have an impact on how people cast their votes this election season. As many as 80 million Americans are expected to vote early, by mail or in person, Tom Bonier, CEO of TargetSmart, a Democratic political data firm, told Axios in August.